SCLX scilexholding.com: Rasio nilai perusahaan marang pendapatan

scilexholding.com (SCLX) - logo korporat

High debt and reliance on non-opioid patents are weighing on Scilex Holding Company (SCLX) shares, as evidenced by the EV/Sales ratio. The value 3391.65 reflects the current magnitude of this metric. Business stability relies on strict control over drug logistics and an aggressive bonus system for expert sales representatives who drive revenue growth.

SCLX: Multiplikator EV/Sales Scilex Holding Company 23.11.2025 - 21.11.2026

Scilex Holding - rincian analitis lan metrik utama (SCLX)

- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
Pambiji fundamental:Scilex Holding Company SCLX
Produk dadi Scilex

A portfolio analyst utilizes this tool to identify undervalued leaders within the pharmaceutical sector. The metric compares the total enterprise value, including debt, against annual revenue, thereby eliminating the impact of capital structure. For Scilex Holding Company (SCLX), this calculation reflects the market value of the commercialization of ZTlido patches and non-opioid solutions. The EV/Sales trend captures the efficiency of drug monetization. Analyzing the chart helps distinguish an investment discount from systemic risks of declining revenues.

Analisis pesaing Scilex Holding Company

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|Nilai bisnis marang pendapatan CPRX|denalitherapeutics.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Harmony Pharma HRMY|BHVN: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PRAX (Praxis Medicines)|Rasio nilai perusahaan marang pendapatan Anavex Life Sciences (AVXL)|Rasio nilai perusahaan marang pendapatan CBLL (CeriBell EEG)|Multiplikator EV/Sales PRTA (Prothena Corp)|alector.com (ALEC) - Multiplikator nilai perusahaan marang pendapatan|ANNX: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Omeros|NGNE: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AC Immune|Nilai perusahaan marang pendapatan VYGR|Rasio nilai perusahaan marang pendapatan NMRA (neumoratx.com)|Nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Multiplikator EV/Sales Alpha Cognition Inc (ACOG)|Multiplikator EV/Sales CGTX (cogrx.com)|Rasio total nilai perusahaan marang pendapatan Inhibikase Pharma (IKT)|SAVA: Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Assertio ASRT|COYA (coyatherapeutics.com) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan VTGN|OVID (Ovid Therapeutics) - Multiplikator EV/Sales|Acumen Pharmaceuticals, Inc (ABOS) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan CervoMed, Inc. (CRVO)|ATHE - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales CLNN (Clene Inc.)|Rasio total nilai perusahaan marang pendapatan PepGen Inc. (PEPG)|JUNS - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Relmada Corp|ANVS (Annovis Bio, Inc.) - Nilai perusahaan marang pendapatan|Grace Tx (GRCE) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AIFF|Multiplikator EV/Sales anewmeds.com|Rasio nilai perusahaan marang pendapatan NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Nilai bisnis marang pendapatan|MetaVia - Nilai perusahaan marang pendapatan|NRXS: Rasio nilai perusahaan marang pendapatan|Helius Medical Technologies, Inc. - Multiplikator EV/Sales|PASG: Rasio nilai perusahaan marang pendapatan|Neuphoria (NEUP) - Rasio nilai perusahaan marang pendapatan|Minerva Neurosciences - Nilai bisnis marang pendapatan|ATHA (Athira Pharma, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan addextherapeutics.com ADXN|Nilai perusahaan marang pendapatan ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PTIX (Protagenic)|Multiplikator EV/Sales pasitheaclinics.com KTTA|CRGT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ATXI (Avenue Therapeutics)|BCLI: Multiplikator EV/Sales|Cara Therapeutics - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Chromocell Therapeutics Corporation|Multiplikator EV/Sales Eliem Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE